Brief: The Oncology Institute Reports Fourth Quarter And Full Year 2022 Financial Results
March 9 (Reuters) - Oncology Institute Inc TOI.O :
* THE ONCOLOGY INSTITUTE REPORTS FOURTH QUARTER AND FULL
YEAR 2022
FINANCIAL RESULTS AND GUIDANCE FOR 2023
* ONCOLOGY INSTITUTE INC - QTRLY LOSS PER SHARE $0.15
* ONCOLOGY INSTITUTE INC SEES 2023 REVENUE BETWEEN $290 TO
$320
MILLION
Source text for Eikon: ID:nGNX9Qj04R
Further company coverage: TOI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncology Institute
See all newsOncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions